Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario P Colombo

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Cancer Research|October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic deathRoberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.
Cell Reports|September 30, 2016
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell ActivitySabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, et al.
Stem Cells (Dayton, Ohio)|August 16, 2005
Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cellsMichela Aluigi, Miriam Fogli, Antonio Curti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing miceVincenzo Bronte, Paolo Serafini, Carmela De Santo, et al.
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Pigment Cell & Melanoma Research|June 30, 2011
Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanomaGianfranco Mattia, M Cristina Errico, Federica Felicetti, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2021
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, ItalyMatteo Bellone, Marco Bregni, Vincenzo Bronte, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Cancer Immunology Research|October 30, 2014
Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironmentLuca Danelli, Barbara Frossi, Giorgia Gri, et al.
Cancer Discovery|November 6, 2013
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphomaSabina Sangaletti, Claudio Tripodo, Caterina Vitali, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Cancer Research|October 2, 2010
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic deathRoberta Zappasodi, Serenella M Pupa, Gaia C Ghedini, et al.
Cell Reports|September 30, 2016
Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell ActivitySabina Sangaletti, Claudio Tripodo, Alessandra Santangelo, et al.
Stem Cells (Dayton, Ohio)|August 16, 2005
Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cellsMichela Aluigi, Miriam Fogli, Antonio Curti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 24, 2002
IL-4-induced arginase 1 suppresses alloreactive T cells in tumor-bearing miceVincenzo Bronte, Paolo Serafini, Carmela De Santo, et al.
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Pigment Cell & Melanoma Research|June 30, 2011
Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanomaGianfranco Mattia, M Cristina Errico, Federica Felicetti, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2021
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, ItalyMatteo Bellone, Marco Bregni, Vincenzo Bronte, et al.
The Journal of Clinical Investigation|April 17, 2003
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomasClaudia Curcio, Emma Di Carlo, Raphael Clynes, et al.
Cancer Immunology Research|October 30, 2014
Mast cells boost myeloid-derived suppressor cell activity and contribute to the development of tumor-favoring microenvironmentLuca Danelli, Barbara Frossi, Giorgia Gri, et al.
Cancer Discovery|November 6, 2013
Defective stromal remodeling and neutrophil extracellular traps in lymphoid tissues favor the transition from autoimmunity to lymphomaSabina Sangaletti, Claudio Tripodo, Caterina Vitali, et al.
Pageof 15